Off-label uses of biologics in dermatology: rituximab, omalizumab, infliximab, etanercept, adalimumab, efalizumab, and alefacept (part 2 of 2). (Q36693091)
Jump to navigation
Jump to search
scientific article published on 7 November 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Off-label uses of biologics in dermatology: rituximab, omalizumab, infliximab, etanercept, adalimumab, efalizumab, and alefacept (part 2 of 2). |
scientific article published on 7 November 2006 |
Statements
1 reference
Off-label uses of biologics in dermatology: rituximab, omalizumab, infliximab, etanercept, adalimumab, efalizumab, and alefacept (part 2 of 2). (English)
1 reference
Julia E Graves
1 reference
Kara Nunley
1 reference
Michael P Heffernan
1 reference
7 November 2006
1 reference
1 reference
Identifiers
1 reference